Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Willcox

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Human Immunology|October 20, 1999
A susceptibility region for myasthenia gravis extending into the HLA-class I sector telomeric to HLA-CM Janer, A Cowland, J Picard, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1991
Critical role for the Val/Gly86 HLA-DR beta dimorphism in autoantigen presentation to human T cellsB Ong, N Willcox, P Wordsworth, et al.
Annals of the New York Academy of Sciences|July 21, 1998
Antibodies affecting ion channel function in acquired neuromyotonia, in seropositive and seronegative myasthenia gravis, and in antibody-mediated arthrogryposis multiplex congenitaA Vincent, L Jacobson, P Plested, et al.
Clinical and Experimental Immunology|February 6, 2013
Anti-cytokine autoantibodies suggest pathogenetic links with autoimmune regulator deficiency in humans and miceJ Kärner, A Meager, M Laan, et al.
Annals of the New York Academy of Sciences|November 1, 2003
Scenarios for autoimmunization of T and B cells in myasthenia gravisH Shiono, I Roxanis, W Zhang, et al.
Journal of Clinical Immunology|October 26, 2013
Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhoodA S B Wolff, A K Sarkadi, L Maródi, et al.
The Journal of Pathology|March 6, 2007
Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1)P Ströbel, A Murumägi, R Klein, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Human Immunology|October 20, 1999
A susceptibility region for myasthenia gravis extending into the HLA-class I sector telomeric to HLA-CM Janer, A Cowland, J Picard, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1991
Critical role for the Val/Gly86 HLA-DR beta dimorphism in autoantigen presentation to human T cellsB Ong, N Willcox, P Wordsworth, et al.
Annals of the New York Academy of Sciences|July 21, 1998
Antibodies affecting ion channel function in acquired neuromyotonia, in seropositive and seronegative myasthenia gravis, and in antibody-mediated arthrogryposis multiplex congenitaA Vincent, L Jacobson, P Plested, et al.
Clinical and Experimental Immunology|February 6, 2013
Anti-cytokine autoantibodies suggest pathogenetic links with autoimmune regulator deficiency in humans and miceJ Kärner, A Meager, M Laan, et al.
Annals of the New York Academy of Sciences|November 1, 2003
Scenarios for autoimmunization of T and B cells in myasthenia gravisH Shiono, I Roxanis, W Zhang, et al.
Journal of Clinical Immunology|October 26, 2013
Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhoodA S B Wolff, A K Sarkadi, L Maródi, et al.
The Journal of Pathology|March 6, 2007
Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1)P Ströbel, A Murumägi, R Klein, et al.
Pageof 9